米国の血管アクセスデバイス市場：製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測、2018年～2032年

米国の血管アクセスデバイスの市場規模は、予測期間の2025年～2032年に5.59％のCAGRで拡大し、2024年の18億2,275万米ドルから2032年には28億2,064万米ドルに成長すると予測されています。がん、腎不全、糖尿病などの慢性疾患の有病率の上昇により、頻繁な血管インターベンションが必要となります。抗感染性カテーテルや圧力監視カテーテルの開発を含む技術の進歩は、患者の安全性と手技効率を大幅に向上させる。さらに、外来治療への嗜好の高まりと外来手術センターの拡大が、高度な血管アクセスソリューションの需要を促進しています。

例えば、Becton Dickinson and Company (BD) は、2024年10月にBD EZI-O腹腔内血管アクセスシステムを発売しました。この最先端ツールは、クリティカルケア患者に緊急時の迅速な血管アクセスを提供します。緊急の医療ニーズに対応するために考案されたこの技術は、骨髄を通して水分や薬剤を迅速かつ効果的に供給することができます。この技術革新の目的は、特にショック、心停止、外傷のような困難な状況におけるケアの質を向上させることです。

米国における入院率の上昇と慢性疾患負担の増加

米国では、がん、心血管疾患、糖尿病、慢性腎臓病などの慢性疾患の蔓延が、血管アクセスデバイスの需要を大きく牽引しています。人口の高齢化と生活習慣病全体の増加に伴い、長期の点滴治療、透析、化学療法を必要とする患者の数は着実に増加しています。これらの治療には通常、血流への頻繁または継続的なアクセスが必要であり、血管アクセスデバイスが不可欠となっています。さらに、外科手術や重症患者サポートのための入院や外来患者の急増は、信頼性が高く効率的な血管アクセスソリューションの需要を高めています。米国ヘルスケアシステムが患者の安全性向上とカテーテル関連合併症の減少にシフトし続けているため、生体適合性と感染予防機能が強化された高度な血管アクセスデバイスの使用も増加しています。このことは、血管アクセスに対するヘルスケアの幅広いニーズと、患者管理における血管アクセスの中心的役割を裏付けています。例えば、2024年2月、CDCは、米国の成人の約10人に6人が少なくとも1つの慢性疾患を持ち、10人に4人が2つ以上の慢性疾患を持ち、入院や長期介護の必要性が著しく増加しているというデータを発表しました。

当レポートでは、米国の血管アクセスデバイス市場について調査し、市場の概要とともに、製品タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国の関税の影響

第4章 エグゼクティブサマリー

第5章 米国の血管アクセスデバイス市場の見通し、2018年～2032年

• 市場規模分析と予測
• 市場シェア分析と予測
  • 製品タイプ別
    • 中心血管アクセスデバイス
    • 末梢血管アクセスデバイス
    • アクセサリ
  • 用途別
    • 医薬品管理局
    • 水分と栄養の投与
    • 輸血
    • 診断
  • エンドユーザー別
    • 病院
    • クリニック
    • 外来手術センター
    • その他
  • 地域別
    • 北東部
    • 中西部
    • 西部
    • 南部
  • 企業別市場シェア分析（上位5社およびその他- 金額別、2024年）
• 2024年の市場マップ分析

第6章 バリューチェーン分析

第7章 需要供給分析

第8章 輸出入の分析

第9章 ポーターのファイブフォース分析

第10章 PESTLE分析

第11章 価格分析

第12章 市場力学

• 市場の促進要因
• 市場の課題

第13章 市場動向と発展

第14章 規制枠組みとイノベーション

第15章 競合情勢

• 市場リーダートップ5の競合マトリックス
• 参入企業トップ5のSWOT分析
• 市場の主要企業トップ10の情勢
  • Becton Dickinson and Company
  • Teleflex Incorporated
  • Nipro Medical Corporation
  • ICU Medical, Inc.
  • AngioDynamics, Inc.
  • Medtronic plc
  • Braun Holding GMBH & Co. KG
  • Terumo Corporation
  • Cook Medical Inc.
  • Access Vascular Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. United States Vascular Access Devices Market, By Value, In USD Million, 2018-2032F
• Figure 2. United States Vascular Access Devices Market, By Volume, In Units, 2018-2032F
• Figure 3. United States Vascular Access Devices Market Share (%), By Product Type, 2018-2032F
• Figure 4. United States Vascular Access Devices Market Share (%), By Application, 2018-2032F
• Figure 5. United States Vascular Access Devices Market Share (%), By End-user, 2018-2032F
• Figure 6. United States Vascular Access Devices Market Share (%), By Region, 2018-2032F
• Figure 7. By Product Type Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 8. By Application Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 9. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 10. By Region Map-Market Size (USD Million) & Growth Rate (%), 2024

United States vascular access devices market is projected to witness a CAGR of 5.59% during the forecast period 2025-2032, growing from USD 1,822.75 million in 2024 to USD 2,820.64 million in 2032. The rising prevalence of chronic conditions such as cancer, renal failure, and diabetes requires frequent vascular interventions. Technological advancements, including developing anti-infective and pressure-monitoring catheters, significantly improve patient safety and procedural efficiency. Moreover, the growing preference for outpatient care and the expansion of ambulatory surgical centers are fueling the demand for advanced vascular access solutions.

For instance, Becton, Dickinson and Company (BD) launched the BD EZI-O Intraosseous Vascular Access System in October 2024. This cutting-edge tool offers critical care patients' quick vascular access in emergencies. The technique, which was created to meet urgent medical needs, allows quick and effective delivery of fluids and medications through bone marrow. The goal of the innovation is to improve the quality of care, especially in difficult situations like shock, cardiac arrest, or trauma.

Rising Hospitalization Rates and Increasing Chronic Disease Burden in the U.S.

The growing prevalence of chronic diseases such as cancer, cardiovascular disorders, diabetes, and chronic kidney disease is significantly driving the demand for vascular access devices in the United States. With the aging population and an overall increase in lifestyle-related illnesses, the number of patients requiring long-term intravenous treatments, dialysis, or chemotherapy is rising steadily. These treatments typically involve frequent or continuous access to the bloodstream, making vascular access devices essential. Furthermore, the surge in hospital admissions and outpatient visits for surgical procedures and critical care support enhances the demand for reliable and efficient vascular access solutions. As the U.S. healthcare system continues to shift toward improving patient safety and reducing catheter-related complications, the usage of advanced vascular access devices with enhanced biocompatibility and infection-prevention features is also increasing. This driver underscores the broader healthcare need for vascular access and its central role in patient management. For example, in February 2024, the CDC published data showing that about 6 in 10 adults in the United States have at least one chronic disease, and 4 in 10 have two or more, significantly increasing hospital admissions and long-term care needs.

Technological Advancements in Vascular Access Devices Improve Patient Safety and Outcomes

Continuous innovation in vascular access technologies has been a significant growth factor in the United States market. Manufacturers focus on developing catheters and associated components that minimize the risk of bloodstream infections, thrombosis, and mechanical failures. Advanced coatings such as antimicrobial and antithrombogenic layers, integrated stabilization features, and closed catheter systems are widely used to enhance safety and reduce hospital-acquired infections. In addition, the integration of imaging-guided placement techniques such as ultrasound and real-time catheter tip positioning systems has improved the precision of device insertion and reduced complications. These technologies enhance patient safety and comfort and enable care providers to reduce the overall cost of complications and reductions. The growing demand for devices that support long-term access with minimal interventions is leading hospitals and clinics across the United States. to increasingly adopt next-generation vascular access devices, thereby contributing to overall market growth. Moreover, in July 2023, Access Vascular Inc. announced positive clinical results from its HydroPICC catheter, a peripheral vascular access device that significantly reduced complications like thrombosis and occlusion in a real-world clinical setting.

Peripheral Vascular Access Devices Hold a Significant Market Share

Peripheral vascular access devices represent a significant segment of the United States vascular access devices market, primarily due to their widespread use across multiple clinical applications. These devices are commonly used in inpatient and outpatient settings for short-term therapies such as hydration, medication delivery, and diagnostic testing. Their minimally invasive nature, ease of insertion, and lower complication rates make them a preferred option for emergency care, pediatric treatments, and routine hospital procedures. Midline catheters and peripheral intravenous (PIV) lines have seen increased adoption due to their suitability for intermediate-duration therapies, reducing the need for more invasive central lines. With an increasing number of ambulatory surgeries and a rise in emergency department visits across the United States, peripheral vascular access solutions are in high demand. Their versatility, cost-effectiveness, and growing technological improvements-such as self-sealing valves and securement systems-further accelerate the segment's growth trajectory. In May 2023, Teleflex Incorporated launched the Arrow VPS Rhythm DLX Device, a vascular positioning system with electrocardiogram-based tip confirmation technology, aimed at enhancing precision and patient safety during catheter placements.

Future Market Scenario (2025-2032F)

The United States vascular access devices market is expected to witness robust growth due to rising hospital admissions, the increasing burden of chronic diseases, and technological innovations in catheter materials and placement systems. Growing demand for minimally invasive procedures and enhanced infection prevention measures will also support market expansion. Additionally, supportive reimbursement frameworks and ongoing clinical innovations are likely to create new opportunities across hospitals and ambulatory surgical centers. BD (Becton, Dickinson and Company) introduced the PIVO Pro, a ground-breaking needleless blood collection tool, in November 2023. Upon FDA approval, the device became the first to function smoothly with both integrated and long-term peripheral IV catheters, including the Nexiva system, which now features NearPort IV Access.

Key Players Landscape and Outlook

The key players in the market are significantly investing in the development of vascular access devices and are utilizing strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing large-cap industry players to increase their presence and, therefore, find new opportunities in this market.

Mozarc Medical, a joint venture between Medtronic (India Medtronic Private Limited) and DaVita Inc., aimed at promoting advancements in kidney treatment, was established in April 2023. Mozarc wants to improve accessibility and flexibility for people with chronic renal disease by creating home-based and portable dialysis systems. The program demonstrates both businesses' dedication to using technology and patient-centered care to revolutionize kidney health management.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. United States Vascular Access Devices Market Outlook, 2018-2032F

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product Type
    • 5.2.1.1. Central Vascular Access Device
    • 5.2.1.2. Peripheral Vascular Access Device
    • 5.2.1.3. Accessories
  • 5.2.2. By Application
    • 5.2.2.1. Drug Administration
    • 5.2.2.2. Fluid and Nutrition Administration
    • 5.2.2.3. Blood Transfusion
    • 5.2.2.4. Diagnostics
  • 5.2.3. By End-user
    • 5.2.3.1. Hospitals
    • 5.2.3.2. Clinics
    • 5.2.3.3. Ambulatory Surgical Centers
    • 5.2.3.4. Others
  • 5.2.4. By Region
    • 5.2.4.1. Northeast
    • 5.2.4.2. Midwest
    • 5.2.4.3. West
    • 5.2.4.4. South
  • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 5.3. Market Map Analysis, 2024
  • 5.3.1. By Product Type
  • 5.3.2. By Application
  • 5.3.3. By End-user
  • 5.3.4. By Region

6. Value Chain Analysis

7. Demand Supply Analysis

8. Import and Export Analysis

9. Porter's Five Forces Analysis

10. PESTLE Analysis

11. Pricing Analysis

12. Market Dynamics

• 12.1. Market Drivers
• 12.2. Market Challenges

13. Market Trends and Developments

14. Regulatory Framework and Innovation

15. Competitive Landscape

• 15.1. Competition Matrix of Top 5 Market Leaders
• 15.2. SWOT Analysis for Top 5 Players
• 15.3. Key Players Landscape for Top 10 Market Players
  • 15.3.1. Becton, Dickinson and Company
    • 15.3.1.1. Company Details
    • 15.3.1.2. Key Management Personnel
    • 15.3.1.3. Products and Services
    • 15.3.1.4. Financials (As Reported)
    • 15.3.1.5. Key Market Focus and Geographical Presence
    • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 15.3.2. Teleflex Incorporated
  • 15.3.3. Nipro Medical Corporation
  • 15.3.4. ICU Medical, Inc.
  • 15.3.5. AngioDynamics, Inc.
  • 15.3.6. Medtronic plc
  • 15.3.7. Braun Holding GMBH & Co. KG
  • 15.3.8. Terumo Corporation
  • 15.3.9. Cook Medical Inc.
  • 15.3.10. Access Vascular Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer